Building upon the established effectiveness of alpha‐glucosidase inhibitors in CRC, as previously outlined in a preliminary literature review, we will first examine the expression of MGAM as a direct target of these drugs in CRC. The gene discussed is GAA; the disease is colorectal carcinoma.